Risk of leukemia after chemotherapy and radiation treatment for breast cancer

Volume 326:1745-1751		June 25, 1992		Number 26

Risk of leukemia after chemotherapy and radiation treatment for breast cancer

RE Curtis, JD Boice, M Stovall, L Bernstein, RS Greenberg, JT Flannery, AG Schwartz, P Weyer, WC Moloney, and RN Hoover

Abstract

Add to Personal Archive

Add to Citation Manager

E-mail When Cited

PubMed Citation

Radiation Epidemiology Branch, National Cancer Institute, Bethesda, Md. 20892.

This article has been cited by other articles:

Eriguchi, M., Oka, H., Mizobuchi, T., Kamimura, T., Sugawara, K., Harada, A. (2009). Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone. Nephrol Dial Transplant 24: 3082-3088 [Abstract] [Full Text]
Chakraborty, S., Sun, C.-L., Francisco, L., Sabado, M., Li, L., Chang, K. L., Forman, S., Bhatia, S., Bhatia, R. (2009). Accelerated Telomere Shortening Precedes Development of Therapy-Related Myelodysplasia or Acute Myelogenous Leukemia After Autologous Transplantation for Lymphoma. JCO 27: 791-798 [Abstract] [Full Text]
Beadle, G., Baade, P., Fritschi, L. (2009). Acute myeloid leukemia after breast cancer: a population-based comparison with hematological malignancies and other cancers. Ann Oncol 20: 103-109 [Abstract] [Full Text]
Ono, M., Watanabe, T., Shimizu, C., Hiramoto, N., Goto, Y., Yonemori, K., Kouno, T., Ando, M., Tamura, K., Katsumata, N., Fujiwara, Y. (2008). Therapy-Related Acute Promyelocytic Leukemia Caused by Hormonal Therapy and Radiation in a Patient with Recurrent Breast Cancer. Jpn J Clin Oncol 38: 567-570 [Abstract] [Full Text]
Schaapveld, M., Visser, O., Louwman, M. J., de Vries, E. G.E., Willemse, P. H.B., Otter, R., van der Graaf, W. T.A., Coebergh, J.-W. W., van Leeuwen, F. E. (2008). Risk of New Primary Nonbreast Cancers After Breast Cancer Treatment: A Dutch Population-Based Study. JCO 26: 1239-1246 [Abstract] [Full Text]
Bernatsky, S, Joseph, L, Boivin, J-F, Gordon, C, Urowitz, M, Gladman, D, Fortin, P R, Ginzler, E, Bae, S-C, Barr, S, Edworthy, S, Isenberg, D, Rahman, A, Petri, M, Alarcon, G S, Aranow, C, Dooley, M-A, Rajan, R, Senecal, J-L, Zummer, M, Manzi, S, Ramsey-Goldman, R, Clarke, A E (2008). The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study. Ann Rheum Dis 67: 74-79 [Abstract] [Full Text]
Bastianutto, C., Mian, A., Symes, J., Mocanu, J., Alajez, N., Sleep, G., Shi, W., Keating, A., Crump, M., Gospodarowicz, M., Medin, J., Minden, M., Liu, F.-F. (2007). Local Radiotherapy Induces Homing of Hematopoietic Stem Cells to the Irradiated Bone Marrow. Cancer Res. 67: 10112-10116 [Abstract] [Full Text]
Patt, D. A., Duan, Z., Fang, S., Hortobagyi, G. N., Giordano, S. H. (2007). Acute Myeloid Leukemia After Adjuvant Breast Cancer Therapy in Older Women: Understanding Risk. JCO 25: 3871-3876 [Abstract] [Full Text]
Le Deley, M.-C., Suzan, F., Cutuli, B., Delaloge, S., Shamsaldin, A., Linassier, C., Clisant, S., de Vathaire, F., Fenaux, P., Hill, C. (2007). Anthracyclines, Mitoxantrone, Radiotherapy, and Granulocyte Colony-Stimulating Factor: Risk Factors for Leukemia and Myelodysplastic Syndrome After Breast Cancer. JCO 25: 292-300 [Abstract] [Full Text]
Travis, L. B. (2007). Evaluation of the Risk of Therapy-Associated Complications in Survivors of Hodgkin Lymphoma. ASH Education Book 2007: 192-196 [Abstract] [Full Text]
Travis, L. B. (2006). The Epidemiology of Second Primary Cancers. Cancer Epidemiol. Biomarkers Prev. 15: 2020-2026 [Abstract] [Full Text]
Fenske, T. S., McMahon, C., Edwin, D., Jarvis, J. C., Cheverud, J. M., Minn, M., Mathews, V., Bogue, M. A., Province, M. A., McLeod, H. L., Graubert, T. A. (2006). Identification of candidate alkylator-induced cancer susceptibility genes by whole genome scanning in mice.. Cancer Res. 66: 5029-5038 [Abstract] [Full Text]
Young, S. D., Whissell, M., Noble, J. C.S., Cano, P. O., Lopez, P. G., Germond, C. J. (2006). Phase II Clinical Trial Results Involving Treatment with Low-Dose Daily Oral Cyclophosphamide, Weekly Vinblastine, and Rofecoxib in Patients with Advanced Solid Tumors.. Clin. Cancer Res. 12: 3092-3098 [Abstract] [Full Text]
d'Errico, F. (2006). Dosimetric issues in radiation protection of radiotherapy patients. Radiat Prot Dosimetry 118: 205-212 [Abstract] [Full Text]
Davis, S, International Consortium For Research On The Healt, , Day, R., Kopecky, K., Mahoney, M., McCarthy, P., Michalek, A., Moysich, K., Onstad, L., Stepanenko, V., Voilleque, P., Other members of Study Team:, , Chegerova, T, Falkner, K, Kulikov, S, Maslova, E, Ostapenko, V, Rivkind, N, Shevchuk, V, Tsyb, A. (2006). Childhood leukaemia in Belarus, Russia, and Ukraine following the Chernobyl power station accident: results from an international collaborative population-based case-control study. Int J Epidemiol 35: 386-396 [Abstract] [Full Text]
Travis, L. B., Rabkin, C. S., Brown, L. M., Allan, J. M., Alter, B. P., Ambrosone, C. B., Begg, C. B., Caporaso, N., Chanock, S., DeMichele, A., Figg, W. D., Gospodarowicz, M. K., Hall, E. J., Hisada, M., Inskip, P., Kleinerman, R., Little, J. B., Malkin, D., Ng, A. K., Offit, K., Pui, C.-H., Robison, L. L., Rothman, N., Shields, P. G., Strong, L., Taniguchi, T., Tucker, M. A., Greene, M. H. (2006). Cancer Survivorship--Genetic Susceptibility and Second Primary Cancers: Research Strategies and Recommendations. JNCI J Natl Cancer Inst 98: 15-25 [Abstract] [Full Text]
Shin, S. J., Chun, S. H., Kim, K. O., Kim, M. K., Lee, K. H., Hyun, M. S., Cho, H. S. (2005). Myelodysplastic Syndrome with Complex Karyotypic Abnormality in a Patient with Waldenstrom's Macroglobulinemia after Sequential Treatment with Chlorambucil and Fludarabine. Jpn J Clin Oncol 35: 622-625 [Abstract] [Full Text]
Campone, M., Roche, H., Kerbrat, P., Bonneterre, J., Romestaing, P., Fargeot, P., Namer, M., Monnier, A., Montcuquet, P., Goudier, M.-J., Fumoleau, P., On behalf of the FASG (French Adjuvant Study Group, (2005). Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group. Ann Oncol 16: 1343-1351 [Abstract] [Full Text]
Praga, C., Bergh, J., Bliss, J., Bonneterre, J., Cesana, B., Coombes, R. C., Fargeot, P., Folin, A., Fumoleau, P., Giuliani, R., Kerbrat, P., Hery, M., Nilsson, J., Onida, F., Piccart, M., Shepherd, L., Therasse, P., Wils, J., Rogers, D. (2005). Risk of Acute Myeloid Leukemia and Myelodysplastic Syndrome in Trials of Adjuvant Epirubicin for Early Breast Cancer: Correlation With Doses of Epirubicin and Cyclophosphamide. JCO 23: 4179-4191 [Abstract] [Full Text]
Wefel, J. S., Meyers, C. A. (2005). Cancer as a Risk Factor for Dementia: A House Built on Shifting Sand. JNCI J Natl Cancer Inst 97: 788-789 [Full Text]
Pruneri, G., Cinieri, S., Peccatori, F., Viale, G. (2005). Unusual Cases in Multiple Myeloma and a Dramatic Response in Metastatic Lung Cancer: CASE 2. Plasma Cell Myeloma Coexisting With Metastatic Breast Carcinoma in the Bone Marrow. JCO 23: 232-233 [Full Text]
Truong, P. T., Olivotto, I. A., Whelan, T. J., Levine, M. (2004). Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. CMAJ 170: 1263-1273 [Abstract] [Full Text]
Andre, M., Mounier, N., Leleu, X., Sonet, A., Brice, P., Henry-Amar, M., Tilly, H., Coiffier, B., Bosly, A., Morel, P., Haioun, C., Gaulard, P., Reyes, F., Gisselbrecht, C., the Groupe d'Etude des Lymphomes de l'Adulte, (2004). Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients. Blood 103: 1222-1228 [Abstract] [Full Text]
Crump, M., Tu, D., Shepherd, L., Levine, M., Bramwell, V., Pritchard, K. (2003). Risk of Acute Leukemia Following Epirubicin-Based Adjuvant Chemotherapy: A Report From the National Cancer Institute of Canada Clinical Trials Group. JCO 21: 3066-3071 [Abstract] [Full Text]
Beaumont, M., Sanz, M., Carli, P.M., Maloisel, F., Thomas, X., Detourmignies, L., Guerci, A., Gratecos, N., Rayon, C., San Miguel, J., Odriozola, J., Cahn, J.Y., Huguet, F., Vekhof, A., Stamatoulas, A., Dombret, H., Capote, F., Esteve, J., Stoppa, A.M., Fenaux, P. (2003). Therapy-Related Acute Promyelocytic Leukemia. JCO 21: 2123-2137 [Abstract] [Full Text]
Arriagada, R., Gutierrez, J. (2003). Anthracyclines: is more, better and/or more dangerous?. Ann Oncol 14: 663-665 [Full Text]
Bernard-Marty, C., Mano, M., Paesmans, M., Accettura, C., Munoz-Bermeo, R., Richard, T., Kleiber, K., Cardoso, F., Lobelle, J. P., Larsimont, D., Piccart, M. J., Di Leo, A. (2003). Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients. Ann Oncol 14: 693-698 [Abstract] [Full Text]
Rauscher, G. H., Sandler, D. P., Poole, C., Pankow, J., Shore, D., Bloomfield, C. D., Olshan, A. F. (2003). Is Family History of Breast Cancer a Marker of Susceptibility to Exposures in the Incidence of de Novo Adult Acute Leukemia?. Cancer Epidemiol. Biomarkers Prev. 12: 289-294 [Abstract] [Full Text]
Kroger, N., Zander, A. R., Martinelli, G., Ferrante, P., Moraleda, J. M., Da Prada, G. A., Demirer, T., Socie, G., Rosti, G. (2003). Low incidence of secondary myelodysplasia and acute myeloid leukemia after high-dose chemotherapy as adjuvant therapy for breast cancer patients: a study by the Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation. Ann Oncol 14: 554-558 [Abstract] [Full Text]
Smith, R. E., Bryant, J., DeCillis, A., Anderson, S. (2003). Acute Myeloid Leukemia and Myelodysplastic Syndrome After Doxorubicin-Cyclophosphamide Adjuvant Therapy for Operable Breast Cancer: The National Surgical Adjuvant Breast and Bowel Project Experience. JCO 21: 1195-1204 [Abstract] [Full Text]
Metayer, C., Curtis, R. E., Vose, J., Sobocinski, K. A., Horowitz, M. M., Bhatia, S., Fay, J. W., Freytes, C. O., Goldstein, S. C., Herzig, R. H., Keating, A., Miller, C. B., Nevill, T. J., Pecora, A. L., Rizzo, J. D., Williams, S. F., Li, C.-Y., Travis, L. B., Weisdorf, D. J. (2003). Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study. Blood 101: 2015-2023 [Abstract] [Full Text]
Ghalie, R G, Mauch, E, Edan, G, Hartung, H P, Gonsette, R E, Eisenmann, S, Le Page, E, Butine, M D, Goodkin, D E (2002). A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis. Mult Scler 8: 441-445 [Abstract]
Colleoni, M., Rocca, A., Sandri, M. T., Zorzino, L., Masci, G., Nole, F., Peruzzotti, G., Robertson, C., Orlando, L., Cinieri, S., Braud, F. d., Viale, G., Goldhirsch, A. (2002). Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels. Ann Oncol 13: 73-80 [Abstract] [Full Text]
National Institutes of Health Consensus Developmen, (2001). National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000. J Natl Cancer Inst Monogr 2001: 5-15 [Abstract] [Full Text]
Partridge, A. H., Burstein, H. J., Winer, E. P. (2001). Side Effects of Chemotherapy and Combined Chemohormonal Therapy in Women With Early-Stage Breast Cancer. J Natl Cancer Inst Monogr 2001: 135-142 [Abstract] [Full Text]
(2001). National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000. JNCI J Natl Cancer Inst 93: 979-989 [Abstract] [Full Text]
Shapiro, C. L., Recht, A. (2001). Side Effects of Adjuvant Treatment of Breast Cancer. NEJM 344: 1997-2008 [Full Text]
van Besien, K., Kelta, M., Bahaguna, P. (2001). Primary Mediastinal B-Cell Lymphoma: A Review of Pathology and Management. JCO 19: 1855-1864 [Abstract] [Full Text]
Recht, A., Edge, S. B., Solin, L. J., Robinson, D. S., Estabrook, A., Fine, R. E., Fleming, G. F., Formenti, S., Hudis, C., Kirshner, J. J., Krause, D. A., Kuske, R. R., Langer, A. S., Sledge, G. W. Jr, Whelan, T. J., Pfister, D. G. (2001). Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology. JCO 19: 1539-1569 [Abstract] [Full Text]
Chaplain, G., Milan, C., Sgro, C., Carli, P.-M., Bonithon-Kopp, C. (2000). Increased Risk of Acute Leukemia After Adjuvant Chemotherapy for Breast Cancer: A Population-Based Study. JCO 18: 2836-2842 [Abstract] [Full Text]
Travis, L. B., Andersson, M., Gospodarowicz, M., van Leeuwen, F. E., Bergfeldt, K., Lynch, C. F., Curtis, R. E., Kohler, B. A., Wiklund, T., Storm, H., Holowaty, E., Hall, P., Pukkala, E., Sleijfer, D. T., Clarke, E. A., Boice, J. D. Jr., Stovall, M., Gilbert, E. (2000). Treatment-Associated Leukemia Following Testicular Cancer. JNCI J Natl Cancer Inst 92: 1165-1171 [Abstract] [Full Text]
Benson, K., Hartz, A. J. (2000). A Comparison of Observational Studies and Randomized, Controlled Trials. NEJM 342: 1878-1886 [Abstract] [Full Text]
Whelan, T. J., Julian, J., Wright, J., Jadad, A. R., Levine, M. L. (2000). Does Locoregional Radiation Therapy Improve Survival in Breast Cancer? A Meta-Analysis. JCO 18: 1220-1229 [Abstract] [Full Text]
Krishnan, A., Bhatia, S., Slovak, M. L., Arber, D. A., Niland, J. C., Nademanee, A., Fung, H., Bhatia, R., Kashyap, A., Molina, A., O'Donnell, M. R., Parker, P. A., Sniecinski, I., Snyder, D. S., Spielberger, R., Stein, A., Forman, S. J. (2000). Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood 95: 1588-1593 [Abstract] [Full Text]
Travis, L. B., Holowaty, E. J., Bergfeldt, K., Lynch, C. F., Kohler, B. A., Wiklund, T., Curtis, R. E., Hall, P., Andersson, M., Pukkala, E., Sturgeon, J., Stovall, M., Storm, H., Clarke, E. A., Boice, J. D., Gospodarowicz, M. (1999). Risk of Leukemia after Platinum-Based Chemotherapy for Ovarian Cancer. NEJM 340: 351-357 [Abstract] [Full Text]
Smith, M. A., Rubinstein, L., Anderson, J. R., Arthur, D., Catalano, P. J., Freidlin, B., Heyn, R., Khayat, A., Krailo, M., Land, V. J., Miser, J., Shuster, J., Vena, D. (1999). Secondary Leukemia or Myelodysplastic Syndrome After Treatment With Epipodophyllotoxins. JCO 17: 569-569 [Abstract] [Full Text]
Riemer, G., Lamszus, K., Zschaber, R., Freitag, H. J., Eggers, C., Pfeiffer, G. (1999). Isolated angiitis of the central nervous system: Lack of inflammation after long-term treatment. Neurology 52: 196-196 [Abstract] [Full Text]
de Lima, M., Strom, S. S., Keating, M., Kantarjian, H., Pierce, S., O'Brien, S., Freireich, E., Estey, E. (1997). Implications of Potential Cure in Acute Myelogenous Leukemia: Development of Subsequent Cancer and Return to Work. Blood 90: 4719-4724 [Abstract] [Full Text]
(1992). RISK OF LEUKEMIA AFTER TREATMENT FOR BREAST CANCER. JWatch General 1992: 1-1 [Full Text]

Comments and questions? Please contact us.